The latest immunotherapy news and developments
Researchers have developed an immunotherapeutic antibody therapy that re-educates macrophages to activate passivated cytotoxic T…
A new study has identified a drug that potentially could make a common type of…
With their ability to treat a wide a variety of diseases, spherical nucleic acids (SNAs)…
Researchers have discovered that a combination of immune checkpoint blockade and targeted therapies that block…
Results from the randomized, phase III KEYNOTE-426 clinical trial show that first-line therapy with a…
Researchers have learned why some glioblastomas, which are the most common type of brain cancer…
A research team at the University of Louisville has discovered that an immune checkpoint molecule…
Collaborative research by The Wistar Institute and Moffitt Cancer Center has demonstrated that BRAF targeted…
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after…
Using genetic engineering, physician and scientist Christopher Klebanoff, has led a team of researchers to…